Operationalisation of post-COVID condition case definition in a comprehensive research protocol.

IF 4.5 2区 医学 Q1 CLINICAL NEUROLOGY European Journal of Neurology Pub Date : 2024-11-13 DOI:10.1111/ene.16543
Federico Masserini, Alessia Nicotra, Arianna Forgione, Francesca Calcaterra, Elena Perdixi, Clara Di Vito, Anna Carletti, Chiara Gallo, Pietro Emiliano Doneddu, Fabrizia Terenghi, Simone Pomati, Eduardo Nobile-Orazio, Agostino Riva, Domenico Mavilio, Leonardo Pantoni
{"title":"Operationalisation of post-COVID condition case definition in a comprehensive research protocol.","authors":"Federico Masserini, Alessia Nicotra, Arianna Forgione, Francesca Calcaterra, Elena Perdixi, Clara Di Vito, Anna Carletti, Chiara Gallo, Pietro Emiliano Doneddu, Fabrizia Terenghi, Simone Pomati, Eduardo Nobile-Orazio, Agostino Riva, Domenico Mavilio, Leonardo Pantoni","doi":"10.1111/ene.16543","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and purpose: </strong>Post-COVID-19 condition (PCC) is a prevalent and high-burden sequela of SARS-CoV-2 infection. Because of the complexity of its manifestations, PCC case definition currently lacks standardisation and reproducibility. We aimed to devise a simple screening tool to boost reproducibility and comparability of PCC case definition across PCC studies, and to provide a framework in which to reliably identify suspected PCC cases. We also developed a comprehensive assessment protocol based on the most frequently reported PCC characteristics.</p><p><strong>Methods: </strong>Within a European multi-centre study and based on the conclusions of a previous systematic review, we devised a checklist to assess the presence of PCC-associated symptoms and their temporal relationship with COVID-19.</p><p><strong>Results: </strong>The checklist was developed to include three symptom cores (cognitive, psychiatric, and general). For each symptom, onset is assessed within 3 months after COVID-19 resolution and persistence for at least 2 months. Any symptom fulfilling this criterion is sufficient to prompt suspicion of PCC. At least one symptom is required in the cognitive or psychiatric domains to suspect PCC with neuropsychiatric involvement. Our protocol features an extensive neuropsychological evaluation and self-administered scales for mood, anxiety, stress-related symptoms, sleep disorders, quality of life, disability, mental health, and personality traits; scales for quantitative assessment of fatigue and headache are also included.</p><p><strong>Conclusions: </strong>Consistent identification of PCC cases is crucial to correctly include patients in research and clinical studies. We propose a simple, reproducible, and flexible screening tool and a proposal for a comprehensive assessment that could be employed to enhance standardisation and comparability.</p>","PeriodicalId":11954,"journal":{"name":"European Journal of Neurology","volume":" ","pages":"e16543"},"PeriodicalIF":4.5000,"publicationDate":"2024-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/ene.16543","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background and purpose: Post-COVID-19 condition (PCC) is a prevalent and high-burden sequela of SARS-CoV-2 infection. Because of the complexity of its manifestations, PCC case definition currently lacks standardisation and reproducibility. We aimed to devise a simple screening tool to boost reproducibility and comparability of PCC case definition across PCC studies, and to provide a framework in which to reliably identify suspected PCC cases. We also developed a comprehensive assessment protocol based on the most frequently reported PCC characteristics.

Methods: Within a European multi-centre study and based on the conclusions of a previous systematic review, we devised a checklist to assess the presence of PCC-associated symptoms and their temporal relationship with COVID-19.

Results: The checklist was developed to include three symptom cores (cognitive, psychiatric, and general). For each symptom, onset is assessed within 3 months after COVID-19 resolution and persistence for at least 2 months. Any symptom fulfilling this criterion is sufficient to prompt suspicion of PCC. At least one symptom is required in the cognitive or psychiatric domains to suspect PCC with neuropsychiatric involvement. Our protocol features an extensive neuropsychological evaluation and self-administered scales for mood, anxiety, stress-related symptoms, sleep disorders, quality of life, disability, mental health, and personality traits; scales for quantitative assessment of fatigue and headache are also included.

Conclusions: Consistent identification of PCC cases is crucial to correctly include patients in research and clinical studies. We propose a simple, reproducible, and flexible screening tool and a proposal for a comprehensive assessment that could be employed to enhance standardisation and comparability.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
在一项综合研究方案中,对 COVID 后病情病例定义进行操作化。
背景和目的:CoVID-19 后遗症(PCC)是感染 SARS-CoV-2 后的一种普遍且负担沉重的后遗症。由于其表现复杂,PCC 病例的定义目前缺乏标准化和可重复性。我们的目标是设计一种简单的筛查工具,以提高不同 PCC 研究中 PCC 病例定义的可重复性和可比性,并提供一个可靠识别疑似 PCC 病例的框架。我们还根据最常报道的 PCC 特征制定了综合评估方案:方法:在一项欧洲多中心研究中,根据之前系统性综述的结论,我们设计了一份核对表来评估是否存在 PCC 相关症状及其与 COVID-19 的时间关系:该核对表包括三个症状核心(认知症状、精神症状和一般症状)。对于每种症状,都要评估其在 COVID-19 解除后 3 个月内发病,且持续至少 2 个月的情况。符合这一标准的任何症状都足以引起对 PCC 的怀疑。如果怀疑 PCC 涉及神经精神疾病,则至少需要在认知或精神领域出现一种症状。我们的方案包括广泛的神经心理学评估和情绪、焦虑、压力相关症状、睡眠障碍、生活质量、残疾、心理健康和人格特质的自编量表;还包括疲劳和头痛的定量评估量表:结论:要将患者正确纳入研究和临床研究,对 PCC 病例进行一致的识别至关重要。我们提出了一种简单、可重复和灵活的筛查工具,并建议采用一种综合评估方法来提高标准化和可比性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
European Journal of Neurology
European Journal of Neurology 医学-临床神经学
CiteScore
9.70
自引率
2.00%
发文量
418
审稿时长
1 months
期刊介绍: The European Journal of Neurology is the official journal of the European Academy of Neurology and covers all areas of clinical and basic research in neurology, including pre-clinical research of immediate translational value for new potential treatments. Emphasis is placed on major diseases of large clinical and socio-economic importance (dementia, stroke, epilepsy, headache, multiple sclerosis, movement disorders, and infectious diseases).
期刊最新文献
Association of left atrial function with vascular brain injury: The Atherosclerosis Risk in Communities study. Phenotype-genotype correlation in X-linked Charcot-Marie-Tooth disease: A French cohort study. Positive signs from the history as an aid for early diagnosis in functional movement disorders: The prospective TASMAN study. Trajectories of physical activity after ischaemic stroke: Exploring prediction of change. Cerebral cortical encephalitis in adults with myelin oligodendrocyte glycoprotein antibody-associated disease: A national case series.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1